Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05829928 · ClinicalTrials.gov registry record
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
A clinical trial of Gender Dysphoria and Transgender, sponsored by University of Pittsburgh.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05829928 is a study of Gender Dysphoria and Transgender that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 150 participants, roughly in line with the 160-participant average among 8 other Gender Dysphoria trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05829928, a study of Gender Dysphoria and Transgender, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. Optimize techniques for processing and cryopreserving testicular tissue. 2. Determine presence and number of germ cells (sperm precursors) in the patients' testicular tissue. 3. Develop next generation cell- and tissue-based therapies for preserving fertility and treating infertility.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Infectious Disease Testing
- PROCEDURE Gonadal Tissue Removal
Study Locations (1)
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2029-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05829928
The ClinicalTrials.gov registry entry for NCT05829928 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 160-participant average among 8 other Gender Dysphoria trials with a reported enrollment target. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gender Dysphoria appearing as the primary indexed condition, and to 2 interventions - of which Infectious Disease Testing is the first listed.
NCT05829928 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05829928 about?
NCT05829928 is a clinical study titled "Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy". The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. Optimize techniques for processing and cryopreserving testicular tissue. 2. Determine presence and number of germ cells (sperm precursors) in the pat...
What is the current status of trial NCT05829928?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2019-05-09. Estimated completion is 2029-05.
What conditions does trial NCT05829928 study?
This clinical trial studies the following conditions: Gender Dysphoria, Transgender.
What interventions are being tested in trial NCT05829928?
The interventions under investigation include: Infectious Disease Testing (DIAGNOSTIC_TEST), Gonadal Tissue Removal (PROCEDURE).
Who is sponsoring clinical trial NCT05829928?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05829928 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Dysphoria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
RECRUITING
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Effect of Nitropaste in Chest Masculinizing Surgery
RECRUITING · Phase 4
-
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.